|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety comparison of liraglutide,glimepiride,and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (liraglutide effect and action in diabetes)-2 study显示文摘 | Nauck M Frid A Hermansen K | | Diabetes Care0，，： | 2 |
| 2 | Great Basin land management planning using ecological modeling显示文摘 | Forbis T A Provencher L Frid L | 2006 | Environmental Management2006，38，1： | 1 |
| 3 | Vigilance by female Dali's sheep:interactions between predation risk factors显示文摘 | FRID A | 1997 | Animal Behaviour1997，53，： | 1 |
| 4 | Treatment of renal artery aneurysm with the multilayer stent显示文摘 | Henry M Polydorou A Frid N | | 0，，02： | 1 |
| 5 | Impaired glucose tolerance associated with adverse pregnancy outcomes: A population-based study in southern Sweden显示文摘 | Aberg A Rydhstroem H Frid Anders | 2001 | Am J Obstet& Gynecol2001，184，： | 1 |
| 6 | Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD(liraglutide effect and action in diabetes)-2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | Diabetes Care2009，32，1： | 1 |
| 7 | Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with mefformin in type 2 diabetes: 2-year results from the LEAD-2 study显示文摘 | Nauck M Frid A Hermansen K | 2013 | Diabetes Obes Metab2013，150，： | 1 |
| 8 | Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage显示文摘 | FRID M G BRUNETTI J A BURKE D L | 2006 | Am J Pathol2006，168，2： | 1 |
| 9 | Evaluation of soil pollution by heavy metals and arsenic in chelyabinsk oblast显示文摘 | Grakovskii V G Frid A S Timokhin P A | 1997 | Eurasian Soil Science1997，30，1： | 1 |
| 10 | Human caused disturbance stimuli as a form of predation risk显示文摘 | Frid A Dill LM | | 0，，： | 1 |
| 11 | Efficacy and safety comparison of liraglutide,glimepiride, and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (Liraglutide Effect and Action in Diabetes )-2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | J Diabetes Care2009，32，1： | 1 |
| 12 | Documented adventage of insulin Lantus when compared with NPH insulin显示文摘 | Frid A | 2004 | Lakartidningen2004，101，39： | 1 |
| 13 | Efficacy and safety comparison ofliraglutide, glimepiride, and placebo, all in combination with metformin, intype 2 diabetes: the LEAD -2 study显示文摘 | Nauck M Frid A Hermansen K | 2009 | Diabetes Care2009，32，： | 1 |
| 14 | Efficacy and Safety Comparison of Liraglutide,Glimepiride,and Placebo, All in Combination With Metformin,in type 2 Diabetes显示文摘 | Nauck M Frid A Hermansen K eta/ | 2009 | Diabetes Care2009，32，1： | 1 |
| 15 | Results and analyais of the 2008-2009 Insulin Injection Technique Questionnaire survey显示文摘 | De Coninek C Frid A Gaspar R | 2010 | J Diabetes2010，2，3： | 1 |
| 16 | Efficacy and safety comparison of llraglutlde, gllmeplrlde, and placebo, all in combination with met- formin, in type 2 diabetes: The LEAD ( liraglutlde effect and action in- diabetes) -2 study 显示文摘 | Nauck M Frid A Hermansen K et aI | 2009 | Diabetes Care2009，32，1： | 1 |
| 17 | New injection recommendations for patients with diabetes显示文摘 | Frid A Hirsch L Gaspar R | 2010 | Diabetes Metab2010，36，1： | 1 |
| 18 | Hypoxia-induced pulmonary vascular remodeling:cellular and molecular mechanisms显示文摘 | Stenmark K R Fagan K A Frid M G | 2006 | Circ Res2006，99，7： | 1 |
| 19 | New injection recommendations for patients with diabetes显示文摘 | Frid A Hirsch L Gaspar R | 2010 | Diabetes Metab2010，36，2： | 1 |
| 20 | Efficacy and safety com- parison of liraglutide, glimepiride, and placebo, all in combina- tion with mefformin, in type 2 diabetes: the LEAD ( liraglutide effect and action in diabetes)-2 study显示文摘 | Nauek M Frid A Hermansen K | 2009 | Diabetes Care2009，32，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员